Deep Tech Startups

Crover builds a robotic system that uses "grain-swimming" technology to move beneath stored grain and monitor it in real time. It serves farmers, grain storage operators, and traders in the agricultural supply chain to reduce storage losses and maintain grain quality.

1 investor

Crownstone provides an Indoor Positioning System (IPS) that locates people and objects inside buildings in real time with room-level accuracy. It targets makers of location-aware software applications, offering infrastructure and an SDK for integration into their own apps for use cases like asset tracking, employee safety, and indoor navigation.

1 investor

CryoCloud is a cloud-based platform for cryo-electron microscopy (cryo-EM) data processing and structural biology analysis, serving academic researchers, biotech companies, pharmaceutical firms, and contract research organizations. The platform provides automated algorithms, GPU compute resources, and data storage to process cryo-EM datasets from collection to 3D structure determination.

1 investor

Cryogenetics provides technology and services for preserving aquatic genes, including fish reproduction improvement and cryopreservation, serving research, conservation, and the aquaculture industry. It works with clients, partners, and research institutions across major aquatic regions worldwide.

1 investor

Crystal AI is an AI research group focused on model efficiency and reasoning, developing techniques such as sparsely activated large language models to make models faster and more efficient. Its stated aim is to make advanced AI broadly accessible and affordable.

1 investor

Crystal Computing is an AI research organization focused on developing efficient and reasoning-based language models. The company aims to make advanced AI capabilities accessible and affordable through research into mathematical and physical optimization of model performance.

1 investor

Crystron Tech publishes technical analysis of lithium iron phosphate (LFP) battery cathode manufacturing, examining how the olivine crystal structure drives process and quality-control complexity across cathode active material production. The content focuses on battery materials, supply chains, and materials innovation for the electric vehicle and energy storage industry.

1 investor

Cube Biotech develops the NativeMP™ platform, including Cubipol/SMALP copolymers and active full-length membrane protein targets, for isolating, purifying, and studying membrane proteins such as ion channels. It also offers custom protein services and bead functionalization used by research institutions for applications like antibody generation and Cryo-EM structural analysis.

1 investor

CubicSpace develops real-time adaptive playback technology that optimizes 3D, VR, and spatial content across devices ranging from glasses-free 3D displays to VR headsets like the Meta Quest 3. Its products, including CubicScreen for iPhone, aim to deliver comfortable 3D viewing without eye strain for users and immersive technology innovators.

1 investor

CUbIQ Technologies develops quantum communication technology, including quantum key distribution (QKD) demonstrated in a QSFP-28 pluggable form factor. The Dutch company works in the quantum cryptography and secure communications field.

1 investor

Cullgen is a privately held biopharmaceutical company developing first-in-class drugs based on its uSMITE™ (small-molecule induced ubiquitin-dependent target elimination) targeted protein degradation platform, which uses the ubiquitin-proteasome system and E3 ubiquitin ligases to target disease-causing proteins that conventional small-molecule drugs cannot reach. The company focuses on oncology and immune-related diseases and operates R&D and offices in both China and the United States.

1 investor

Cultured Computer is a research lab studying how to give AI a continuous sense of context and consistent persona so that interactions feel human and stay coherent. Its work spans social psychology, cognitive architectures, world models, and context engineering for AI that adapts to the people it serves.

1 investor

CureAge Therapeutics develops a cell delivery platform targeting Schwann cells for treating neurofibromatosis type 1 (NF1) peripheral tumors. The company emerged from a partnership between the Children's Tumor Foundation and Deep Science Ventures to address unmet needs in the neurofibromatosis patient community.

1 investor

Curida is a contract development and manufacturing organization (CDMO) that provides end-to-end development and manufacturing of sterile and non-sterile liquid pharmaceuticals, with specialized expertise in nasal sprays and ophthalmic solutions. The company serves pharmaceutical partners ranging from startups to major pharmaceutical firms across 80+ countries.

1 investor

Cursive is a European AI lab developing frontier artificial intelligence, focusing on systems designed to be useful, inspectable, adaptable, and aligned with human judgment.

1 investor

CY Vision builds 3D augmented-reality head-up display (AR HUD) technology for vehicles, delivering true 3D imagery across multiple depth planes with a wide field of view while running on existing vehicle compute and sensor systems. Its displays target automakers across compact cars, SUVs, and commercial trucks to reduce eyes-off-road time and highlight hazards, lane markers, and signage.

1 investor

Cyanomin develops a biological desalination process that uses bacteria with electrically charged biofilms to adsorb and remove ions from hypersaline brines, treating wastewater without membranes, pressure, or heat. It serves industries that generate hypersaline wastewater, including oil & gas, lithium and copper extraction, and seawater desalination.

1 investor

Cyberwave provides an infrastructure platform that abstracts robots, sensors, and autonomous systems behind universal APIs, with digital twins for simulation and orchestration tools to deploy and manage device fleets through code. It serves developers and enterprises building on physical systems across robotics, autonomous navigation, sensor fusion, and edge AI.

1 investor

Cyclicor is a deeptech material science company developing isocyanate-free and biobased polyurethanes. Its polymer materials are used for adhesives (hotmelt and liquid), coatings, elastomers, TPU, and foam.

1 investor

Cycuity provides Radix security analysis and verification tools that detect security weaknesses in semiconductor designs, from IP blocks and RTL to full SoCs with firmware. It serves semiconductor manufacturers and defense, automotive, and data center hardware developers seeking to prevent chip vulnerabilities and achieve compliance.

1 investor

CyGenica develops GEENIE, an engineered protein nanoneedle for intracellular drug delivery that bypasses endosomes to deliver therapeutic molecules such as nucleotides and proteins directly inside cells. The technology targets treatments for cancers and rare disorders and is offered to biopharmaceutical partners.

1 investor

Cyndr offers a capability intelligence platform that maps organisations, research activity, and technologies across national security and emerging technology ecosystems. It helps investors—including venture capital firms, strategic investors, and government-backed innovation funds—discover emerging companies, evaluate technology relevance, and monitor developments across defence, intelligence, and national security domains.

1 investor

Cytochroma provides genetically diverse iPSC-derived human cell models, high-throughput screening, and phenotypic data (branded "Wet AI") for drug discovery and preclinical validation. It serves pharmaceutical and biotech teams seeking donor-matched, multi-lineage cell panels across diverse populations to support safety, efficacy, and regulatory testing.

1 investor

Cytomos develops AuraCyt®, a microelectronics-based biotechnology platform for real-time single-cell analytics in bioprocessing and cell and gene therapy manufacturing. The company serves large biotech and pharma companies seeking cost-effective process analytical technology solutions for drug development and manufacturing.

1 investor